A federal multidistrict litigation for plaintiffs who allege that their use of over-the-counter Tylenol caused their livers to fail or be poisoned was approved this week to be presided in front of U.S. District Judge Lawrence F. Stengel of the Eastern District of Pennsylvania.
Drugmakers McNeil/Johnson & Johnson, Novartis and L. Perrigo Co. opposed the consolidation of 27 cases in front of Stengel. But McNeil and Perrigo did favor the Eastern District of Pennsylvania as the site of the MDL if one was approved.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
